These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22369133)

  • 1. Maximizing biomarker discovery by minimizing gene signatures.
    Chang C; Wang J; Zhao C; Fostel J; Tong W; Bushel PR; Deng Y; Pusztai L; Symmans WF; Shi T
    BMC Genomics; 2011 Dec; 12 Suppl 5(Suppl 5):S6. PubMed ID: 22369133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selecting a single model or combining multiple models for microarray-based classifier development?--a comparative analysis based on large and diverse datasets generated from the MAQC-II project.
    Chen M; Shi L; Kelly R; Perkins R; Fang H; Tong W
    BMC Bioinformatics; 2011 Oct; 12 Suppl 10(Suppl 10):S3. PubMed ID: 22166133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feature selection and classification of MAQC-II breast cancer and multiple myeloma microarray gene expression data.
    Liu Q; Sung AH; Chen Z; Liu J; Huang X; Deng Y
    PLoS One; 2009 Dec; 4(12):e8250. PubMed ID: 20011240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data.
    Shen R; Ghosh D; Chinnaiyan AM
    BMC Genomics; 2004 Dec; 5(1):94. PubMed ID: 15598354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consistency of predictive signature genes and classifiers generated using different microarray platforms.
    Fan X; Lobenhofer EK; Chen M; Shi W; Huang J; Luo J; Zhang J; Walker SJ; Chu TM; Li L; Wolfinger R; Bao W; Paules RS; Bushel PR; Li J; Shi T; Nikolskaya T; Nikolsky Y; Hong H; Deng Y; Cheng Y; Fang H; Shi L; Tong W
    Pharmacogenomics J; 2010 Aug; 10(4):247-57. PubMed ID: 20676064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fuzzy logic selection as a new reliable tool to identify molecular grade signatures in breast cancer--the INNODIAG study.
    Kempowsky-Hamon T; Valle C; Lacroix-Triki M; Hedjazi L; Trouilh L; Lamarre S; Labourdette D; Roger L; Mhamdi L; Dalenc F; Filleron T; Favre G; François JM; Le Lann MV; Anton-Leberre V
    BMC Med Genomics; 2015 Feb; 8():3. PubMed ID: 25888889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes.
    Warnat P; Eils R; Brors B
    BMC Bioinformatics; 2005 Nov; 6():265. PubMed ID: 16271137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliable gene signatures for microarray classification: assessment of stability and performance.
    Davis CA; Gerick F; Hintermair V; Friedel CC; Fundel K; Küffner R; Zimmer R
    Bioinformatics; 2006 Oct; 22(19):2356-63. PubMed ID: 16882647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Steiner tree-based method for biomarker discovery and classification in breast cancer metastasis.
    Jahid MJ; Ruan J
    BMC Genomics; 2012; 13 Suppl 6(Suppl 6):S8. PubMed ID: 23134806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.
    Shi L; Campbell G; Jones WD; Campagne F; Wen Z; Walker SJ; Su Z; Chu TM; Goodsaid FM; Pusztai L; Shaughnessy JD; Oberthuer A; Thomas RS; Paules RS; Fielden M; Barlogie B; Chen W; Du P; Fischer M; Furlanello C; Gallas BD; Ge X; Megherbi DB; Symmans WF; Wang MD; Zhang J; Bitter H; Brors B; Bushel PR; Bylesjo M; Chen M; Cheng J; Cheng J; Chou J; Davison TS; Delorenzi M; Deng Y; Devanarayan V; Dix DJ; Dopazo J; Dorff KC; Elloumi F; Fan J; Fan S; Fan X; Fang H; Gonzaludo N; Hess KR; Hong H; Huan J; Irizarry RA; Judson R; Juraeva D; Lababidi S; Lambert CG; Li L; Li Y; Li Z; Lin SM; Liu G; Lobenhofer EK; Luo J; Luo W; McCall MN; Nikolsky Y; Pennello GA; Perkins RG; Philip R; Popovici V; Price ND; Qian F; Scherer A; Shi T; Shi W; Sung J; Thierry-Mieg D; Thierry-Mieg J; Thodima V; Trygg J; Vishnuvajjala L; Wang SJ; Wu J; Wu Y; Xie Q; Yousef WA; Zhang L; Zhang X; Zhong S; Zhou Y; Zhu S; Arasappan D; Bao W; Lucas AB; Berthold F; Brennan RJ; Buness A; Catalano JG; Chang C; Chen R; Cheng Y; Cui J; Czika W; Demichelis F; Deng X; Dosymbekov D; Eils R; Feng Y; Fostel J; Fulmer-Smentek S; Fuscoe JC; Gatto L; Ge W; Goldstein DR; Guo L; Halbert DN; Han J; Harris SC; Hatzis C; Herman D; Huang J; Jensen RV; Jiang R; Johnson CD; Jurman G; Kahlert Y; Khuder SA; Kohl M; Li J; Li L; Li M; Li QZ; Li S; Li Z; Liu J; Liu Y; Liu Z; Meng L; Madera M; Martinez-Murillo F; Medina I; Meehan J; Miclaus K; Moffitt RA; Montaner D; Mukherjee P; Mulligan GJ; Neville P; Nikolskaya T; Ning B; Page GP; Parker J; Parry RM; Peng X; Peterson RL; Phan JH; Quanz B; Ren Y; Riccadonna S; Roter AH; Samuelson FW; Schumacher MM; Shambaugh JD; Shi Q; Shippy R; Si S; Smalter A; Sotiriou C; Soukup M; Staedtler F; Steiner G; Stokes TH; Sun Q; Tan PY; Tang R; Tezak Z; Thorn B; Tsyganova M; Turpaz Y; Vega SC; Visintainer R; von Frese J; Wang C; Wang E; Wang J; Wang W; Westermann F; Willey JC; Woods M; Wu S; Xiao N; Xu J; Xu L; Yang L; Zeng X; Zhang J; Zhang L; Zhang M; Zhao C; Puri RK; Scherf U; Tong W; Wolfinger RD;
    Nat Biotechnol; 2010 Aug; 28(8):827-38. PubMed ID: 20676074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome prediction based on microarray analysis: a critical perspective on methods.
    Zervakis M; Blazadonakis ME; Tsiliki G; Danilatou V; Tsiknakis M; Kafetzopoulos D
    BMC Bioinformatics; 2009 Feb; 10():53. PubMed ID: 19200394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer.
    Reyal F; van Vliet MH; Armstrong NJ; Horlings HM; de Visser KE; Kok M; Teschendorff AE; Mook S; van 't Veer L; Caldas C; Salmon RJ; van de Vijver MJ; Wessels LF
    Breast Cancer Res; 2008; 10(6):R93. PubMed ID: 19014521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genes and functions from breast cancer signatures.
    Huang S; Murphy L; Xu W
    BMC Cancer; 2018 Apr; 18(1):473. PubMed ID: 29699511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very Important Pool (VIP) genes--an application for microarray-based molecular signatures.
    Su Z; Hong H; Fang H; Shi L; Perkins R; Tong W
    BMC Bioinformatics; 2008 Aug; 9 Suppl 9(Suppl 9):S9. PubMed ID: 18793473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of multiple genomic signatures demonstrates that classification algorithms choose phenotype-related genes.
    Shi W; Bessarabova M; Dosymbekov D; Dezso Z; Nikolskaya T; Dudoladova M; Serebryiskaya T; Bugrim A; Guryanov A; Brennan RJ; Shah R; Dopazo J; Chen M; Deng Y; Shi T; Jurman G; Furlanello C; Thomas RS; Corton JC; Tong W; Shi L; Nikolsky Y
    Pharmacogenomics J; 2010 Aug; 10(4):310-23. PubMed ID: 20676069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model selection for prognostic time-to-event gene signature discovery with applications in early breast cancer data.
    Ahdesmäki M; Lancashire L; Proutski V; Wilson C; Davison TS; Harkin DP; Kennedy RD
    Stat Appl Genet Mol Biol; 2013 Oct; 12(5):619-35. PubMed ID: 24077567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive sensitivity analysis of microarray breast cancer classification under feature variability.
    Sontrop HM; Moerland PD; van den Ham R; Reinders MJ; Verhaegh WF
    BMC Bioinformatics; 2009 Nov; 10():389. PubMed ID: 19941644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of sufficiently strong informative features limits the potential of gene expression analysis as predictive tool for many clinical classification problems.
    Hess KR; Wei C; Qi Y; Iwamoto T; Symmans WF; Pusztai L
    BMC Bioinformatics; 2011 Dec; 12():463. PubMed ID: 22132775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patients.
    Oberthuer A; Juraeva D; Li L; Kahlert Y; Westermann F; Eils R; Berthold F; Shi L; Wolfinger RD; Fischer M; Brors B
    Pharmacogenomics J; 2010 Aug; 10(4):258-66. PubMed ID: 20676065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.